NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,760 | -99.9% | 3,000 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $8,177,000 | +25.1% | 5,931,000 | +25.3% | 0.17% | +20.8% |
| Q3 2020 | $6,536,000 | -4.4% | 4,733,000 | +15.2% | 0.14% | -10.0% |
| Q2 2020 | $6,839,000 | +23.7% | 4,110,000 | -4.6% | 0.16% | +33.3% |
| Q1 2020 | $5,530,000 | -20.5% | 4,310,000 | -5.0% | 0.12% | -11.1% |
| Q4 2019 | $6,957,000 | -52.5% | 4,537,000 | -57.5% | 0.14% | -50.7% |
| Q3 2019 | $14,633,000 | -4.0% | 10,683,000 | -7.5% | 0.27% | -7.1% |
| Q2 2019 | $15,247,000 | -2.6% | 11,543,000 | -0.1% | 0.30% | -14.5% |
| Q1 2019 | $15,650,000 | +11.7% | 11,558,000 | -1.7% | 0.34% | +1.8% |
| Q4 2018 | $14,016,000 | -13.6% | 11,756,000 | +23.8% | 0.34% | +1.5% |
| Q3 2018 | $16,214,000 | -2.4% | 9,495,000 | -17.1% | 0.33% | -4.6% |
| Q2 2018 | $16,612,000 | – | 11,448,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
| Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
| MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
| Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
| Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
| LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
| Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
| D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |